Dr Dylan Kiltschewskij

Dr Dylan Kiltschewskij

Postdoctoral Research Fellow

School of Biomedical Sciences and Pharmacy

Career Summary

Biography

Dylan Kiltschewskij is a postdoctoral research fellow in Professor Murray Cairns’ complex disorder group. He obtained a Bachelor of Biomedical Science with First Class Honours from The University of Newcastle in 2015 and has since completed his PhD in Medical Genetics. Dylan’s research aims to explore and characterise the nexus between fundamental neuroscience, genetics and psychiatric disorders through implementation of multidimensional high-throughput molecular techniques, systems biology and statistical genetics.  

Dylan’s present work is focussed on leveraging large genome-wide association studies (GWAS) to infer the effect of biochemical exposures on brain structure to identify putative relationships relevant to psychiatric disorders and explore potential drug repurposing opportunities. Dylan is also currently utilizing DNA methylation signals in conjunction with genetic data to refine the identification of individuals with a high burden of genetic and epigenetic risk for schizophrenia, as well as severe cognitive subtypes. Since joining the Cairns lab as an Honours student, Dylan has additionally conducted and published studies exploring the mechanistic basis of microRNA and other noncoding RNAs in neuronal cells by employing a range of RNA sequencing methods, including mRNA-Seq, small RNA-Seq, Ribosome Profiling and Poly(A)-tail sequencing. Collectively, these studies have enabled Dylan to develop expertise in a range of experimental, bioinformatic and statistical techniques, as well as a passion for scientific communication via conferences and social media.

Dylan is proficient in a wide range of laboratory and computational research skills, including:

  • Next-generation RNA sequencing, including multiple library preparation methods and bioinformatic analysis pipelines
  • Analysis of gene expression data 
  • Profiling of small RNA-mRNA interactions 
  • Genome-wide association studies (GWAS) and epigenome-wide association studies (EWAS)
  • Mendelian Randomisation
  • Polygenic and epigenetic risk scoring
  • Tissue culture techniques

Qualifications

  • Doctor of Philosophy in Medical Genetics, University of Newcastle
  • Bachelor of Biomedical Science (Honours), University of Newcastle

Keywords

  • Bioinformatics
  • Epigenetics
  • Genomics
  • Noncoding RNA
  • Psychiatric disorders
  • Statistical genetics
  • Systems biology
  • Transcriptomics

Languages

  • English (Mother)

Fields of Research

Code Description Percentage
310504 Epigenetics (incl. genome methylation and epigenomics) 25
310204 Genomics and transcriptomics 50
310505 Gene expression (incl. microarray and other genome-wide approaches) 25

Professional Experience

UON Appointment

Title Organisation / Department
Postdoctoral Research Fellow University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia
Casual Academic University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia

Awards

Award

Year Award
2016 Australian Postgraduate Award
Australian Federal Government
2016 Research Training Program Stipend Scholarship and Research Training Program Tuition Fee Offset
Australian Federal Government
2015 Faculty of Health and Medicine Medal for outstanding academic achievement
Faculty of Health and Medicine, The University of Newcastle
2014 ADInstruments Prize for Human Structure and Function
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
2014 Australian Soceity of Biochemistry and Molecular Biology Prize for Biomedical Science
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
2014 Life Technologies Prize for Cellular and Molecular Science
School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
2014 Faculty of Health and Medicine Medal for outstanding academic achievement
Faculty of Health and Medicine, University of Newcastle
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Conference (1 outputs)

Year Citation Altmetrics Link
2019 Geaghan M, Kiltschewskij D, Atkins J, Cairns M, 'INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE SCHIZOPHRENIA-ASSOCIATED DYSREGULATION OF MIR-1271-5P EXPRESSION', EUROPEAN NEUROPSYCHOPHARMACOLOGY, Los Angeles, CA (2019)
DOI 10.1016/j.euroneuro.2019.08.181
Co-authors Murray Cairns

Journal article (17 outputs)

Year Citation Altmetrics Link
2025 Kiltschewskij DJ, Reay WR, Cairns MJ, 'Schizophrenia is associated with altered DNA methylation variance', MOLECULAR PSYCHIATRY [C1]
DOI 10.1038/s41380-024-02749-5
Citations Scopus - 4Web of Science - 1
Co-authors Murray Cairns
2025 Kelly C, Kiltschewskij DJ, Leong AJW, Haw TJ, Croft AJ, Balachandran L, Chen D, Bond DR, Lee HJ, Cairns MJ, Sverdlov AL, Ngo DTM, 'Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities: transcriptomic and epigenetic profiling', Scientific Reports, 15 (2025) [C1]

Cancer therapy-related cardiovascular toxicity (CTR-CVT) is now recognised as one of the leading causes of long-term morbidity and mortality in cancer patients. To date... [more]

Cancer therapy-related cardiovascular toxicity (CTR-CVT) is now recognised as one of the leading causes of long-term morbidity and mortality in cancer patients. To date, potential overlapping cardiotoxicity mechanism(s) across different chemotherapeutic classes have not been elucidated. Doxorubicin, an anthracycline, and Carfilzomib, a proteasome inhibitor, are both known to cause heart failure in some patients. Given this common cardiotoxic effect of these chemotherapies, we aimed to investigate differential and common mechanism(s) associated with Doxorubicin and Carfilzomib-induced cardiac dysfunction. Primary human cardiomyocyte-like cells (HCM-ls) were treated with 1¿µM of either Doxorubicin or Carfilzomib for 72¿h. Both Doxorubicin and Carfilzomib induced a significant reduction in HCM cell viability and cell damage. DNA methylation analysis performed using MethylationEPIC array showed distinct and common changes induced by Doxorubicin and Carfilzomib (10,270 or approximately 12.9% of the DMPs for either treatment overlapped). RNA-seq analyses identified 5,643 differentially expressed genes (DEGs) that were commonly dysregulated for both treatments. Pathway analysis revealed that the PI3K-Akt signalling pathway was the most significantly enriched pathway with common DEGs, shared between Doxorubicin and Carfilzomib. We identified that there are shared cardiotoxicity mechanisms for Doxorubicin and Carfilzomib pathways that can be potential therapeutic targets for treatments across 2 classes of anti-cancer agents.

DOI 10.1038/s41598-025-87442-5
Co-authors Heather Lee, Tattjhong Haw, Murray Cairns, Aaron Sverdlov, Danielle Bond, Doan Ngo
2024 Reay WR, Kiltschewskij DJ, Di Biase MA, Gerring ZF, Kundu K, Surendran P, Greco LA, Clarke ED, Collins CE, Mondul AM, Albanes D, Cairns MJ, 'Genetic influences on circulating retinol and its relationship to human health', NATURE COMMUNICATIONS, 15 (2024) [C1]
DOI 10.1038/s41467-024-45779-x
Citations Scopus - 1Web of Science - 4
Co-authors Clare Collins, Murray Cairns, Erin Clarke, Laura Greco
2024 Rootes-Murdy K, Panta S, Kelly R, Romero J, Quide Y, Cairns MJ, Loughland C, Carr VJ, Catts S, Jablensky A, Green MJ, Henskens F, Kiltschewskij D, Michie PT, Mowry B, Pantelis C, Rasser PE, Reay WR, Schall U, Scott RJ, Watkeys OJ, Roberts G, Mitchell PB, Fullerton JM, Overs BJ, Kikuchi M, Hashimoto R, Matsumoto J, Fukunaga M, Sachdev PS, Brodaty H, Wen W, Jiang J, Fani N, Ely TD, Lorio A, Stevens JS, Ressler K, Jovanovic T, van Rooij SJH, Federmann LM, Jockwitz C, Teumer A, Forstner AJ, Caspers S, Cichon S, Plis SM, Sarwate AD, Calhoun VD, 'Cortical similarities in psychiatric and mood disorders identified in federated VBM analysis via COINSTAC', PATTERNS, 5 (2024) [C1]

Structural neuroimaging studies have identified a combination of shared and disorder-specific patterns of gray matter (GM) deficits across psychiatric disorders. Poolin... [more]

Structural neuroimaging studies have identified a combination of shared and disorder-specific patterns of gray matter (GM) deficits across psychiatric disorders. Pooling large data allows for examination of a possible common neuroanatomical basis that may identify a certain vulnerability for mental illness. Large-scale collaborative research is already facilitated by data repositories, institutionally supported databases, and data archives. However, these data-sharing methodologies can suffer from significant barriers. Federated approaches augment these approaches by enabling access or more sophisticated, shareable and scaled-up analyses of large-scale data. We examined GM alterations using Collaborative Informatics and Neuroimaging Suite Toolkit for Anonymous Computation, an open-source, decentralized analysis application. Through federated analysis of eight sites, we identified significant overlap in the GM patterns (n = 4,102) of individuals with schizophrenia, major depressive disorder, and autism spectrum disorder. These results show cortical and subcortical regions that may indicate a shared vulnerability to psychiatric disorders.

DOI 10.1016/j.patter.2024.100987
Co-authors Murray Cairns, Rodney Scott, Frans Henskens, Pat Michie, Carmel Loughland
2024 Duchatel RJ, Jackson ER, Parackal SG, Kiltschewskij D, Findlay IJ, Mannan A, Staudt DE, Thomas BC, Germon ZP, Laternser S, Kearney PS, Jamaluddin MFB, Douglas AM, Beitaki T, McEwen HP, Persson ML, Hocke EA, Jain V, Aksu M, Manning EE, Murray HC, Verrills NM, Sun CX, Daniel P, Vilain RE, Skerrett-Byrne DA, Nixon B, Hua S, de Bock CE, Colino-Sanguino Y, Valdes-Mora F, Tsoli M, Ziegler DS, Cairns MJ, Raabe EH, Vitanza NA, Hulleman E, Phoenix TN, Koschmann C, Alvaro F, Dayas C, Tinkle CL, Wheeler H, Whittle JR, Eisenstat DD, Firestein R, Mueller S, Valvi S, Hansford JR, Ashley DM, Gregory SG, Kilburn LB, Nazarian J, Cain JE, Dun MD, 'PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma', JOURNAL OF CLINICAL INVESTIGATION, 134 (2024) [C1]
DOI 10.1172/JCI170329
Citations Scopus - 2Web of Science - 8
Co-authors David Skerrett-Byrne, Susan Hua, Zacary Germon, Evie Jackson, Heather Murray, Lizzie Manning, Matt Dun, Ryan Duchatel, Brett Nixon, Nikki Verrills, Christopher Dayas, Murray Cairns
2024 Kiltschewskij DJ, Reay WR, Geaghan MP, Atkins JR, Xavier A, Zhang X, Watkeys OJ, Carr VJ, Scott RJ, Green MJ, Cairns MJ, 'Alteration of DNA Methylation and Epigenetic Scores Associated With Features of Schizophrenia and Common Variant Genetic Risk', BIOLOGICAL PSYCHIATRY, 95, 647-661 (2024) [C1]
DOI 10.1016/j.biopsych.2023.07.010
Citations Scopus - 1Web of Science - 6
Co-authors Rodney Scott, Alexandre Xavier, Murray Cairns
2023 Barnett MM, Reay WR, Geaghan MP, Kiltschewskij DJ, Green MJ, Weidenhofer J, Glatt SJ, Cairns MJ, 'miRNA cargo in circulating vesicles from neurons is altered in individuals with schizophrenia and associated with severe disease', SCIENCE ADVANCES, 9 (2023) [C1]
DOI 10.1126/sciadv.adi4386
Citations Scopus - 2Web of Science - 6
Co-authors William Reay Uon, Judith Weidenhofer, Murray Cairns
2023 Kiltschewskij DJ, Harrison PF, Fitzsimmons C, Beilharz TH, Cairns MJ, 'Extension of mRNA poly(A) tails and 3'UTRs during neuronal differentiation exhibits variable association with post-transcriptional dynamics', NUCLEIC ACIDS RESEARCH, 51, 8181-8198 (2023) [C1]
DOI 10.1093/nar/gkad499
Citations Scopus - 9Web of Science - 4
Co-authors Chantel Fitzsimmons, Murray Cairns
2022 Marin FR, Davalos A, Kiltschewskij D, Crespo MC, Cairns M, Andres-Leon E, Soler-Rivas C, 'RNA-Seq, Bioinformatic Identification of Potential MicroRNA-like Small RNAs in the Edible Mushroom Agaricus bisporus and Experimental Approach for Their Validation', INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 23 (2022) [C1]

Although genomes from many edible mushrooms are sequenced, studies on fungal micro RNAs (miRNAs) are scarce. Most of the bioinformatic tools are designed for plants or ... [more]

Although genomes from many edible mushrooms are sequenced, studies on fungal micro RNAs (miRNAs) are scarce. Most of the bioinformatic tools are designed for plants or animals, but the processing and expression of fungal miRNAs share similarities and differences with both kingdoms. Moreover, since mushroom species such as Agaricus bisporus (A. bisporus, white button mushroom) are frequently consumed as food, controversial discussions are still evaluating whether their miRNAs might or might not be assimilated, perhaps within extracellular vesicles (i.e., exosomes). Therefore, the A. bisporus RNA-seq was studied in order to identify potential de novo miRNA-like small RNAs (milRNAs) that might allow their later detection in diet. Results pointed to 1 already known and 37 de novo milRNAs. Three milRNAs were selected for RT-qPCR experiments. Precursors and mature milRNAs were found in the edible parts (caps and stipes), validating the predictions carried out in silico. When their potential gene targets were investigated, results pointed that most were involved in primary and secondary metabolic regulation. However, when the human transcriptome is used as the target, the results suggest that they might interfere with important biological processes related with cancer, infection and neurodegenerative diseases.

DOI 10.3390/ijms23094923
Citations Scopus - 8Web of Science - 4
Co-authors Murray Cairns
2022 Reay WR, Kiltschewskij DJ, Geaghan MP, Atkins JR, Carr VJ, Green MJ, Cairns MJ, 'Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders', SCIENCE ADVANCES, 8 (2022) [C1]
DOI 10.1126/sciadv.abj8969
Citations Scopus - 6Web of Science - 55
Co-authors Murray Cairns, William Reay Uon
2022 Kiltschewskij DJ, Reay WR, Cairns MJ, 'Evidence of genetic overlap and causal relationships between blood-based biochemical traits and human cortical anatomy', TRANSLATIONAL PSYCHIATRY, 12 (2022) [C1]
DOI 10.1038/s41398-022-02141-3
Citations Scopus - 1Web of Science - 8
Co-authors Murray Cairns
2022 Pertile RAN, Kiltschewskij D, Geaghan M, Barnett M, Cui X, Cairns MJ, Eyles D, 'Developmental vitamin D-deficiency increases the expression of microRNAs involved in dopamine neuron development', BRAIN RESEARCH, 1789 (2022) [C1]

Schizophrenia is a neurodevelopmental disorder associated with abnormal dopamine (DA) signalling and disruptions in early brain development. We have shown that developm... [more]

Schizophrenia is a neurodevelopmental disorder associated with abnormal dopamine (DA) signalling and disruptions in early brain development. We have shown that developmental vitamin D-deficiency (DVD-deficiency) increases the risk of schizophrenia in offspring and impairs various aspects of brain development in rodents, particularly that of DA neurons, however the molecular basis of these impairments remains unclear. Here, we explore whether small non-coding microRNAs (miRNAs) are involved. miRNAs regulate gene expression post-transcriptionally via translational repression and destabilisation of mRNA. While dysregulation of multiple miRNAs has been reported in post-mortem brain of patients with schizophrenia, the biological pathways affected by these small RNAs are not clear. Here we identified differential expression of 18 miRNAs in DA neurons isolated from DVD-deficient embryos. Three miRNAs were selected for further functional studies of dopaminergic neuron differentiation based on their interactions with transcripts involved in neuronal maturation. In particular, we show upregulation of miR-181c-5p suppresses neurite outgrowth of dopaminergic neurons. These findings provide further evidence that an environmental risk factor for schizophrenia ¿ DVD-deficiency ¿ disrupts the development of DA neurons and suggests increased miRNA expression may be one possible mechanism. This disruption potentially underlies the long-term alterations in DA mediated brain function in DVD-deficient offspring, and by inference in schizophrenia.

DOI 10.1016/j.brainres.2022.147953
Citations Scopus - 1Web of Science - 8
Co-authors Murray Cairns
2022 Pertile RAN, Kiltschewskij D, Geaghan M, Barnett M, Cui X, Cairns MJ, Eyles D, 'Developmental Vitamin D-Deficiency Increases the Expression of MicroRNAs Involved in Dopamine Neuron Development', SSRN Electronic Journal,
DOI 10.2139/ssrn.4029404
2020 Kiltschewskij DJ, Geaghan MP, Cairns MJ, 'Characterising the Transcriptional and Translational Impact of the Schizophrenia-Associated miR-1271-5p in Neuronal Cells', CELLS, 9 (2020) [C1]
DOI 10.3390/cells9041014
Citations Scopus - 4Web of Science - 3
Co-authors Murray Cairns
2020 Kiltschewskij DJ, Cairns MJ, 'Transcriptome-wide analysis of interplay between mrna stability, translation and small RNAs in response to neuronal membrane depolarization', International Journal of Molecular Sciences, 21, 1-23 (2020) [C1]
DOI 10.3390/ijms21197086
Citations Scopus - 7Web of Science - 4
Co-authors Murray Cairns
2020 Mahmoudi E, Kiltschewskij D, Fitzsimmons C, Cairns MJ, 'Depolarization-Associated CircRNA Regulate Neural Gene Expression and in Some Cases May Function as Templates for Translation', CELLS, 9 (2020) [C1]
DOI 10.3390/cells9010025
Citations Scopus - 1Web of Science - 29
Co-authors Murray Cairns, Chantel Fitzsimmons
2019 Kiltschewskij D, Cairns MJ, 'Temporospatial guidance of activity-dependent gene expression by microRNA: mechanisms and functional implications for neural plasticity', NUCLEIC ACIDS RESEARCH, 47, 533-545 (2019) [C1]
DOI 10.1093/nar/gky1235
Citations Scopus - 2Web of Science - 19
Co-authors Murray Cairns
Show 14 more journal articles

Preprint (7 outputs)

Year Citation Altmetrics Link
2025 Brzozowski JS, Sahni S, Murray HC, Watt L, Kiltschewskij D, Cairns MJ, Messina M, Tillett D, Kelso MJ, Verrills NM, 'Bisantrene potentiates tyrosine kinase inhibitor activity in clear cell renal cell carcinoma' (2025)
DOI 10.1101/2025.07.21.665824
Co-authors Murray Cairns, Nikki Verrills
2025 Kiltschewskij D, Reay W, Cairns M, 'A Genetic Atlas of Relationships Between Circulating Metabolites and Liability to Psychiatric Conditions' (2025)
DOI 10.1101/2025.05.19.25327956
Co-authors Murray Cairns
2023 Rootes-Murdy K, Panta S, Kelly R, Romero J, Quidé Y, Cairns M, Loughland C, Carr V, Catts S, Jablensky A, Green M, Henskens F, Kiltschewskij D, Michie P, Mowry B, Pantelis C, Rasser P, Reay W, Schall U, Scott R, Watkeys O, Cairns M, Roberts G, Mitchell P, Fullerton J, Overs B, Kikuchi M, Hashimoto R, Matsumoto J, Fukunaga M, Sachdev P, Brodaty H, Wen W, Jiang J, Fani N, Ely T, Lorio A, Stevens J, Ressler K, Jovanovic T, van Rooij S, Plis S, Sarwate A, Calhoun V, 'Cortical Similarities in Psychiatric and Mood Disorders Identified in Federated VBM Analysis via COINSTAC' (2023)
DOI 10.1101/2023.09.28.23296219
Co-authors Murray Cairns, Frans Henskens, Carmel Loughland, Pat Michie, Rodney Scott, William Reay Uon
2023 Reay W, Kiltschewskij D, Di Biase M, Gerring Z, Kundu K, Surendran P, Greco L, Clarke E, Collins C, Mondul A, Albanes D, Cairns M, 'Genetic influences on circulating retinol and its relationship to human health' (2023)
DOI 10.1101/2023.08.07.23293796
Co-authors Murray Cairns, William Reay Uon, Laura Greco
2021 Reay W, Kiltschewskij D, Geaghan M, Atkins J, Carr V, Green M, Cairns M, 'Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders' (2021)
DOI 10.1101/2021.05.11.21257061
Co-authors William Reay Uon, Murray Cairns
2021 Kiltschewskij D, Reay W, Cairns M, 'Causal effect of C-reactive protein and vitamin D on human cerebral anatomy observed among genetically correlated biomarkers in blood' (2021)
DOI 10.1101/2021.09.11.21263146
Co-authors William Reay Uon, Murray Cairns
2021 Marin F, Dávalos A, Kiltschewskij-Brown D, Crespo M, Cairns M, Andres-Leon E, Soler-Rivas C, 'RNA-seq, bioinformatic identification of potential MicroRNA-Like Small RNAs in the edible mushroom Agaricus bisporus and experimental approach for their validation' (2021)
DOI 10.1101/2021.10.13.464216
Co-authors Murray Cairns
Show 4 more preprints
Edit

Grants and Funding

Summary

Number of grants 7
Total funding $39,000

Click on a grant title below to expand the full details for that specific grant.


Highlighted grants and funding

Utilising Epigenetic Risk for Schizophrenia as a Platform for Precision Medicine$10,000

Funding provided by the School of Biomedical Sciences and Pharmacy for CHMW 2022 Strategic Pilot Grants which narrowly missed College funding. 

Funding body: School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle

Funding body School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
Project Team

Dr Dylan Kiltschewskij, Dr William Reay, Prof Murray Cairns

Scheme College of Health, Medicine and Wellbeing 2022 Strategic Research Pilot Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

CBMHR 2021 Seed Funding Grant$10,000

Funding body: Centre for Brain and Mental Health Research

Funding body Centre for Brain and Mental Health Research
Project Team

Dr Dylan Kiltschewskij, Mr William Reay, Professor Murray Cairns

Scheme Project Grant
Role Lead
Funding Start 2021
Funding Finish 2021
GNo
Type Of Funding Internal
Category INTE
UON N

20224 grants / $23,000

Utilising Epigenetic Risk for Schizophrenia as a Platform for Precision Medicine$10,000

Funding provided by the School of Biomedical Sciences and Pharmacy for CHMW 2022 Strategic Pilot Grants which narrowly missed College funding. 

Funding body: School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle

Funding body School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle
Project Team

Dr Dylan Kiltschewskij, Dr William Reay, Prof Murray Cairns

Scheme College of Health, Medicine and Wellbeing 2022 Strategic Research Pilot Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Utilising Epigenetic Risk for Schizophrenia as a Platform for Precision Medicine$10,000

Funding body: HMRI Precision Medicine Research Program

Funding body HMRI Precision Medicine Research Program
Project Team

Dr Dylan Kiltschewskij, Dr William Reay, Prof Murray Cairns

Scheme 2022 Pilot Grant Scheme
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Precision Medicine Research Program Travel Support Grant$1,500

Funding body: HMRI Precision Medicine Research Program

Funding body HMRI Precision Medicine Research Program
Project Team

Dr Dylan Kiltschewskij

Scheme 2022 Travel Support Grant
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

Precision Medicine Research Program Publication Support Grant$1,500

Funding body: HMRI Precision Medicine Research Program

Funding body HMRI Precision Medicine Research Program
Project Team

Dr Dylan Kiltschewskij

Scheme 2022 Publication Support Scheme
Role Lead
Funding Start 2022
Funding Finish 2022
GNo
Type Of Funding Internal
Category INTE
UON N

20211 grants / $10,000

CBMHR 2021 Seed Funding Grant$10,000

Funding body: Centre for Brain and Mental Health Research

Funding body Centre for Brain and Mental Health Research
Project Team

Dr Dylan Kiltschewskij, Mr William Reay, Professor Murray Cairns

Scheme Project Grant
Role Lead
Funding Start 2021
Funding Finish 2021
GNo
Type Of Funding Internal
Category INTE
UON N

20201 grants / $1,000

CBMHR Publication Support Grant$1,000

Funding body: Centre for Brain and Mental Health Research

Funding body Centre for Brain and Mental Health Research
Scheme CBMHR Publication Support Grant
Role Investigator
Funding Start 2020
Funding Finish 2020
GNo
Type Of Funding Internal
Category INTE
UON N

20181 grants / $5,000

CBMHR Infrastructure Grant$5,000

Funding body: Infrastructure grant, Priority Research Centre for Brain and Mental Health

Funding body Infrastructure grant, Priority Research Centre for Brain and Mental Health
Scheme Infrastructure Grant, Priority Research Centre for Brain and Mental Health
Role Lead
Funding Start 2018
Funding Finish 2018
GNo
Type Of Funding Internal
Category INTE
UON N
Edit

Research Supervision

Number of supervisions

Completed0
Current1

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2025 PhD Leveraging Genetics to Inform Precision Medicine in Common Cancers PhD (Medical Genetics), College of Health, Medicine and Wellbeing, The University of Newcastle Principal Supervisor
Edit

Dr Dylan Kiltschewskij

Positions

Postdoctoral Research Fellow
Molecular Neurobiology
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing

Casual Academic
Molecular Neurobiology
School of Biomedical Sciences and Pharmacy
College of Health, Medicine and Wellbeing

Contact Details

Email dylan.kiltschewskij@newcastle.edu.au
Phone 0249218748
Mobile 0434499681

Office

Room MS616
Building Medical Science
Location Callaghan Campus
University Drive
Callaghan, NSW 2308
Australia
Edit